Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution 16.01.2025 / 17:30 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a ...

Miscellaneous AGRANA holds Capital Markets Day on its new “NEXT LEVEL” strategy 16.01.2025 / 18:50 CET/CEST The issuer is solely responsible for the content of this announcement.

Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next -generation digital services and consulting, delivered strong and broad-based performance with $4,939 ...

Aescuvest Capital Partners (ACP) is at the forefront of Healthtech investing, leveraging its deep expertise in European healthcare innovation to make a global impact. With a focus on ...

ESG Homes for people in need: wienerberger extends partnership with Habitat for Humanity International 15.01.2025 / 08:45 CET/CEST The issuer is solely responsible for the content of this announcement ...

The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market. BAIBYS™, a pioneering Israeli startup in AI-powered micro- ...

Launch of 'Beyond Tennis': A new generative AI tennis league with AI players and data-driven tournaments ...

Nives Doneus investigates old myths about the history of Mediterranean coastal cities and assesses previous research, employing modern remote sensing techniques such as laser scanning to reconstruct ...

BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose ...

Binder Grösswang advised Aptiv PLC, together with the global law firm Clifford Chance, on the sale of Aptiv’s equity share in TTTech Auto AG to the Dutch chipmaker NXP Semiconductors NV. TTTech Auto ...

Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February ...

Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the ...